Literature DB >> 18158115

Survival of skin allografts is prolonged in mice with a dominant-negative H-Ras.

Naoko Funeshima-Fuji1, Masayuki Fujino, Hiromitsu Kimura, Shiro Takahara, Toshinori Nakayama, Taichi Ezaki, Xiao-Kang Li.   

Abstract

Ras is a guanine nucleotide-binding protein that plays a major role in regulating the proliferation of T cells. To investigate the mechanism of the Ras/mitogen-activated protein kinase pathway, one of the downstream signal-transduction pathways of T-cell receptors, in the response to alloantigen, we performed full-thickness skin grafting in the major histocompatibility complex (MHC) incompatible strain BALB/c (H-2Kd) (donor) and T-cell-specific H-Ras dominant-negative (dnRas) transgenic (tg) C57BL/6 (H-2Kb) (recipient) male mice. In vitro and in vivo dnRas tg mouse T-cell proliferation and cytotoxic T lymphocyte (CTL) activity assay were also performed. The median graft survival time in control B6/wild type (wt) mouse allografts was seven days. Conversely, the dnRas tg mouse group exhibited a significant (p<0.01) prolongation of graft survival to 15 days. However, all grafts were eventually rejected after one month. Mixed lymphocyte reaction and popliteal lymph node assay revealed that T-cell proliferation was decreased in response to alloantigen, but CTL activity was not changed in the dnRas tg mice. These results suggested that Ras is essential for peripheral T lymphocytes to respond to allo-MHC antigens, and Ras may be a molecular target for controlling transplant rejection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18158115     DOI: 10.1016/j.trim.2007.10.009

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  2 in total

1.  Fetal fibroblasts and keratinocytes with immunosuppressive properties for allogeneic cell-based wound therapy.

Authors:  Thomas Zuliani; Soraya Saiagh; Anne-Chantal Knol; Julie Esbelin; Brigitte Dréno
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

2.  CICAFAST: comparison of a biological dressing composed of fetal fibroblasts and keratinocytes on a split-thickness skin graft donor site versus a traditional dressing: a randomized controlled trial.

Authors:  Alexandra Poinas; Pierre Perrot; Judith Lorant; Olivier Nerrière; Jean-Michel Nguyen; Soraya Saiagh; Cécile Frenard; Audrey Leduc; Olivier Malard; Florent Espitalier; Franck Duteille; Anne Chiffoleau; Florence Vrignaud; Amir Khammari; Brigitte Dréno
Journal:  Trials       Date:  2019-10-28       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.